SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-05-003163
Filing Date
2005-06-03
Accepted
2005-06-03 17:23:01
Documents
2
Effectiveness Date
2005-06-03

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. DEFA14A b55370ttdefa14a.htm DEFA14A 24218
2 GRAPHIC b55370ttb5537090.gif GRAPHIC 4313
  Complete submission text file 0000950135-05-003163.txt   31616
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21481 | Film No.: 05878512
SIC: 2836 Biological Products, (No Diagnostic Substances)